| Thrifty White Pharmacy #786 | |
| 2018 15th St Nw, Rochester, Minnesota 55901 | |
| (507) 281-1676 |
| Name | Thrifty White Pharmacy #786 |
|---|---|
| Organization Name | Thrifty Drug Stores Inc |
| Location | 2018 15th St Nw, Rochester, Minnesota 55901 |
| Type | Pharmacy |
| Phone | (507) 281-1676 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a significant advance, UC San Francisco Weill Institute for Neurosciences researchers working towards a brain-controlled prosthetic limb have shown that machine learning techniques helped an individual with paralysis learn to control a computer cursor using their brain activity without requiring extensive daily retraining, which has been a requirement of all past brain-computer interface efforts.
Moldova's early actions to fight HIV/AIDS and tuberculosis are slowing the rise of the country's dual tuberculosis and AIDS epidemics, the World Bank reports.
KaVo Kerr Group, a global portfolio of leading dental brands, plans to present 35+ new products at the 36th International Dental Show (IDS) in Cologne. KaVo Kerr Group delivers products and solutions to 99% of dental practices worldwide, making IDS — the world's leading trade fair for the dental industry — the ideal stage to share the latest KaVo Kerr Group has to offer.
Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome.
› Verified 4 days ago
| NPI Number | 1629510854 |
| Organization Name | THRIFTY DRUG STORES INC |
| Type | Pharmacy |
| Address | 2018 15th St Nw, Rochester, MN 55901 |
| Phone Number | 507-281-1676 |
News Archive
In a significant advance, UC San Francisco Weill Institute for Neurosciences researchers working towards a brain-controlled prosthetic limb have shown that machine learning techniques helped an individual with paralysis learn to control a computer cursor using their brain activity without requiring extensive daily retraining, which has been a requirement of all past brain-computer interface efforts.
Moldova's early actions to fight HIV/AIDS and tuberculosis are slowing the rise of the country's dual tuberculosis and AIDS epidemics, the World Bank reports.
KaVo Kerr Group, a global portfolio of leading dental brands, plans to present 35+ new products at the 36th International Dental Show (IDS) in Cologne. KaVo Kerr Group delivers products and solutions to 99% of dental practices worldwide, making IDS — the world's leading trade fair for the dental industry — the ideal stage to share the latest KaVo Kerr Group has to offer.
Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome.
› Verified 4 days ago
News Archive
In a significant advance, UC San Francisco Weill Institute for Neurosciences researchers working towards a brain-controlled prosthetic limb have shown that machine learning techniques helped an individual with paralysis learn to control a computer cursor using their brain activity without requiring extensive daily retraining, which has been a requirement of all past brain-computer interface efforts.
Moldova's early actions to fight HIV/AIDS and tuberculosis are slowing the rise of the country's dual tuberculosis and AIDS epidemics, the World Bank reports.
KaVo Kerr Group, a global portfolio of leading dental brands, plans to present 35+ new products at the 36th International Dental Show (IDS) in Cologne. KaVo Kerr Group delivers products and solutions to 99% of dental practices worldwide, making IDS — the world's leading trade fair for the dental industry — the ideal stage to share the latest KaVo Kerr Group has to offer.
Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome.
› Verified 4 days ago
Anderson's Wheelchair Inc Type: DME Supplier - Customized Equipment Location: 1117 2nd St Sw, Rochester, Minnesota 55902 Phone: (507) 288-0113 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4871 19th St Nw, Rochester, Minnesota 55901 Phone: (507) 285-0065 | |
Corner Medical Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 36 17th Ave Nw, Rochester, Minnesota 55901 Phone: (507) 208-4350 | |
Limb Lab Type: Prosthetic/Orthotic Supplier Location: 400 South Broadway, Rochester, Minnesota 55904 Phone: (507) 322-3457 | |
Gibbons Optical Llc Type: Eyewear Supplier (Equipment, not the service) Location: 150 17th Ave Nw, Rochester, Minnesota 55901 Phone: (507) 288-6964 |